About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Safety and Preliminary Efficacy Study of V404 PDS in Uveitis

NCT02125266·5 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Forsight Vision4

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

18 years of age or older
Confirmed diagnosis of active uveitis
Sufficient lens/media clarity
Meet best-corrected visual acuity criteria
Willing and able to use contraception

You may not be if

Pregnant, breast feeding
Uncontrolled glaucoma
Intraocular surgery or periocular/intraocular injections within 6 weeks
Periocular or intraocular steroid within 3 months
Prior vitrectomy
Prior corneal transplant
Prior fluocinolone implant
Allergy or sensitivity to study drug
Participation in other trial within 30 days
Abnormal liver function
History of positive serum tuberculosis test

The record

StatusTerminated

PhasePhase 1–2

Taking part7

StartedApr 2014

UpdatedDec 9, 2016

Conditions

Uveitis, Posterior Uveitis, Intermediate

Where5

Golden, Colorado, United States
Atlanta, Georgia, United States
Omaha, Nebraska, United States

Clareo Health | Safety and Preliminary Efficacy Study of V404 PDS in Uveitis